These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17891544)

  • 21. Effects of habitat alteration on the epizootiology of Myxobolus cerebralis, the causative agent of salmonid whirling disease.
    Granath WO
    J Parasitol; 2014 Apr; 100(2):157-65. PubMed ID: 24383542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whirling disease of salmonid fish: life cycle, biology, and disease.
    Gilbert MA; Granath WO
    J Parasitol; 2003 Aug; 89(4):658-67. PubMed ID: 14533670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The parasite that causes whirling disease, Myxobolus cerebralis, is genetically variable within and across spatial scales.
    Lodh N; Kerans BL; Stevens L
    J Eukaryot Microbiol; 2012; 59(1):80-7. PubMed ID: 22151695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myxobolus cerebralis in Tubifex tubifex from a whirling disease epizootic in Montana.
    Rognlie MC; Knapp SE
    J Parasitol; 1998 Aug; 84(4):711-3. PubMed ID: 9714199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution and Prevalence of Myxobolus cerebralis in Postfire Areas of Plumas National Forest: Utility of Environmental DNA Sampling.
    Richey CA; Kenelty KV; Van Stone Hopkins K; Stevens BN; Martínez-López B; Barnum SM; Hallett SL; Atkinson SD; Bartholomew JL; Soto E
    J Aquat Anim Health; 2018 Jun; 30(2):130-143. PubMed ID: 29710407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A RNAi-based therapeutic proof of concept targets salmonid whirling disease in vivo.
    Sarker S; Menanteau-Ledouble S; Kotob MH; El-Matbouli M
    PLoS One; 2017; 12(6):e0178687. PubMed ID: 28575083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The susceptibility of diverse species of cultured oligochaetes to the fish parasite Myxobolus pseudodispar Gorbunova (Myxozoa).
    Marton S; Eszterbauer E
    J Fish Dis; 2012 Apr; 35(4):303-14. PubMed ID: 27082060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterisation of carbohydrate-binding sites in developmental stages of Myxobolus cerebralis.
    Knaus M; El-Matbouli M
    Parasitol Res; 2005 Dec; 97(6):505-14. PubMed ID: 16211413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myxobolus cerebralis (Myxozoa), the causative agent of whirling disease, reduces fecundity and feeding activity of Tubifex tubifex (Oligochaeta).
    Shirakashi S; El-Matbouli M
    Parasitology; 2009 May; 136(6):603-13. PubMed ID: 19284888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular phylogeny of tubificid oligochaetes with special emphasis on Tubifex tubifex (Tubificidae).
    Beauchamp KA; Kathman RD; McDowell TS; Hedrick RP
    Mol Phylogenet Evol; 2001 May; 19(2):216-24. PubMed ID: 11341804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cadmium on the susceptibility of Tubifex tubifex to Myxobolus cerebralis (Myxozoa), the causative agent of whirling disease.
    Shirakashi S; El-Matbouli M
    Dis Aquat Organ; 2010 Feb; 89(1):63-70. PubMed ID: 20391913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of water temperature on the development, release and survival of the triactinomyxon stage of Myxobolus cerebralis in its oligochaete host.
    El-Matbouli M; McDowell TS; Antonio DB; Andree KB; Hedrick RP
    Int J Parasitol; 1999 Apr; 29(4):627-41. PubMed ID: 10428640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing the distribution of Myxobolus cerebralis, the causative agent of whirling disease, in the Cache la Poudre River, Colorado.
    Allen MB; Bergersen EP
    Dis Aquat Organ; 2002 Apr; 49(1):51-60. PubMed ID: 12093042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the Long-Term Viability of the Myxospores of Myxobolus cerebralis as Determined by Production of the actinospores by Tubifex tubifex.
    Barry Nehring B; Schisler G; Chiaramonte L; Horton A; Poole B
    J Aquat Anim Health; 2015 Mar; 27(1):50-6. PubMed ID: 26306333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of glycans in the developmental stages of Myxobolus cerebralis (Myxozoa), the causative agent of whirling disease.
    Kaltner H; Stippl M; Knaus M; El-Matbouli M
    J Fish Dis; 2007 Nov; 30(11):637-47. PubMed ID: 17958607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using real-time PCR and Bayesian analysis to distinguish susceptible tubificid taxa important in the transmission of Myxobolus cerebralis, the cause of salmonid whirling disease.
    Fytilis N; Rizzo DM; Lamb RD; Kerans BL; Stevens L
    Int J Parasitol; 2013 May; 43(6):493-501. PubMed ID: 23474394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Light and electron microscopic studies on the chronological development of Myxobolus cerebralis to the actinosporean stage in Tubifex tubifex.
    El-Matbouli M; Hoffmann RW
    Int J Parasitol; 1998 Jan; 28(1):195-217. PubMed ID: 9504346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of Myxobolus cerebralis infection to rainbow trout in the Madison River, Montana, USA.
    Krueger RC; Kerans BL; Vincent ER; Rasmussen C
    Ecol Appl; 2006 Apr; 16(2):770-83. PubMed ID: 16711061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A nested polymerase chain reaction for the detection of genomic DNA of Myxobolus cerebralis in rainbow trout Oncorhynchus mykiss.
    Andree KB; MacConnell E; Hedrick RP
    Dis Aquat Organ; 1998 Oct; 34(2):145-54. PubMed ID: 9828408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of Myxobolus cerebralis (Bivalvulida: Myxobolidae) in two non-Tubifex tubifex oligochaetes in the southeastern USA.
    Ksepka SP; Rash JM; Cai W; Bullard SA
    Dis Aquat Organ; 2021 Jan; 143():51-56. PubMed ID: 33506815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.